Indeed, elevated LINC00460 amounts were significantly associated with poor OS in bladder cancer [13, 71], cervical cancer [16, 17], colorectal cancer [10, 20–22], esophageal cancer [25, 72], gastric cancer [27], HNSCC [39, 40], liver cancer [45], lung cancer [30, 31, 51], osteosarcoma [49, 54], pancreatic cancer [32] and papillary thyroid carcinoma [33]. Here, LINC00460 is linked to pancreatic neoplasm.